Lecture 8 - Obesity, Metabolic Syndrome, Dyslipidaemia Flashcards

1
Q

What is Obesity?

A

It’s an excess of body fat frequently resulting in a significant impairment in health.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Ways to measure overweight and obesity:

A

Height and weight tables:
-considered obese if >20% above desired weight listed

BMI [for adults]

  • overweight <25 kg/m2
  • preobese 25< BMI <29.99 kg/m2
  • Grade 1 obesity: 30< BMI < 34.99 kg/m2
  • Grade 2 obesity: 35 < BMI <39.99 kg/m2
  • Grade 3 obesity: >40kg/m2

Waist Girth:
-Significant risks at WG >102cm for men and WG > 88cm for women.

Waist to Hip Ratio:
- Significant risks at WHR >0.8 for women and >0.9 for men.

Phenotype:

  • Type I = Excess body mass or %fat
  • Type II = Excess subcutaneous truncal-abdominal fat [android]
  • Type III = Excess abdominal visceral fat
  • Type IV = Excess gluteal-femoral fat [gynoid]

Body fat percentage:

  • Significant risks at >25% fat for men and >35% fat for women
  • Skin folds
  • Hydrostatic weighing
  • DEXA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What influences predispose individuals to obesity?

A

BEHAVIOURAL:

  • socioeconomic status [education]
  • activity level
  • nutrition

METABOLIC:

  • genetic factors
  • metabolic and endocrine factors

BIOLOGICAL:

  • Race
  • Gender
  • Age
  • Pregnancy

CULTURAL/SOCIETAL:

  • Media
  • Work Practices
  • Transport
  • Urbanisation/modernisation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Drugs for Treating Obesity:

  1. Phentermine [ Adipex-P, Lonamin]
A

Current weight loss are appropriately recommended for individuals with a BMI >30 or with a BMI>27 if they have obesity relate comorbidities

is recommended for short term use - Acts as an appetite suppressant but causes dry mouth, palpitations, and anxiety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Drugs for Treating Obesity:

  1. Lorcaserin [Belviq]
A

It’s a serotonin receptor agonist: reduces appetite

Given in addition to lifestyle modifications, lose about 2-3kg more than placebo over the course of a year

Side effects: headaches, dizziness, fatigue, nausea, dry mouth and constipation. Rare chemical imbalance [serotonin syndrome], suicidal thoughts, psychiatric problems.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Drugs for treating obesity:

  1. Orlistat [Xenical, Alli]
A

It’s a pancreatic lipase inhibitor: blocks the digestion and absorption of fat in your stomach and intestines.

It decreases fat absorption by 30% = further increase of dietary fat [leakage!!!] - excess fat is release through oily diarrhoea.

Phentermine and Topiramate [Qsymia] [appetite suppresant] = capable of 12% to 14% weight loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Health Benefits of a 10% Weight loss:

A

BP : decline of about 10mmHg is systolic and diastolic BP in patients with hypertension equivalent to that with most BP medication

Diabetes:
Decline of up to 50% in fasting glucose for newly diagnosed patients

Prediabetes:
>30% decline in fasting or 2h post glucose insulin level >30% increase in insulin sensitivity, 40-60% decline in the incidence of diabetes

Lipids:
10% decline in TC
15% decline in LDL chol
30% decline in TRIG
8% increase in HDL chol

Mortality:
>20% decline in all cause mortality
> 30% decline in deaths related to diabetes
>40% decline in deaths related to obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

ACSM Guidelines:

A

Prevent gain weight:

  • 150-250min/week of mod int PA is associated with prevention
  • more than 150min/w of mod int PA is associated with modest weight loss

Weight loss:

  • 150 -250min/week only provides modest weight loss
  • greater amount [>250] provide clinically significant weight loss

For weight maintenance after weight loss:
- there’s some evidence that >250min/week will prevent weight re-gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Exercise prescription:

A

Both cardiorespiratory + resistance
Frequency:4-5 days/week
Duration: 40-60min
Intensity: 50-60% VO2max

RT may not enhance weight loss but may increase/maintain fat free mass and is associated with reductions in health risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Safety concerns during PA for obesity:

A
  1. Musculoskeletal screening recommended for obese clients
  2. 12 lead ECG
  3. BP response
  4. Signs of dyspnoea
  5. Signs of metabolic disturbances [hypoglycaemia] - BGL’s
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Considerations to make when developing physical activity programmes for the severely obese:

A

Barriers:
- Physical, psychological, economic, an programme based

Safety issues:
- co morbid medical conditions

PA options:
- low intensity activity [gardening]; non-weight bearing activity [swimming, water aerobics]; walking [increases caloric expenditure]

Programme goals:
-caloric expenditure and weight loss [300-500kcal/session and 2000 kcal/week], QOL, improved mood, improved physical conditioning

Promoting adherence:
- develop good rapport, patient eduction, address barriers, provide progressive feedback, use prompts and rewards, develop social support.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Management of Metabolic syndrome:

A

If focus is on obesity as underlying cause - prevent and treat obesity

If focus is on insulin resistance as underlying cause - treat insulin resistance and prevent T2D

If focus is on individual risk factors - treat individual risk factors, such as: Low HDL chol, high Total C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Hoes does exercise help:

A

Well as MetS is a clustering of risk factors, exercise helps by reducing/preventing/treating each of them

Exercise is the only therapy that can do so

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Lipids

A

A study exercised 13 men with hyperlipidaemia and 12 men with normal lipids on a treadmill at 70% of peak VO2max. They exhibited a significant decrease in TRIG

A single bout of exercise can increase TRIG removal at the next meal.

Aerobic exercise that’s at least moderate intensity 3x/week can

  • increase HDL-C
  • Reduce total chol, LDL & TRIG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Lowering blood cholesterol:

Primary focus of diet therapy is on lowering LDL-C:

A
  • high saturated fat intake and high dietary chol reduce LDL clearance
  • diets high in polyunsaturated fat may reduce HDL levels
  • high carbohydrate diets may reduce HDL levels and raise TRIG’s
  • monounsaturated fats apparel to lower Total- C and possibly increase HDL levels
  • fibre sequesters bile and can reduce LDL levels by 5-10%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Lowering blood cholesterol:

Advise adults who would benefit from LDL-C lowering to:

A

Consume a dietary pattern that emphasises intake of vegetables, fruits and whole grains; includes low-fat dairy products, poultry, fish, legumes, no tropical vegetable oils, and nuts, and limits intake of sweets, sugar-sweetened beverages and red meats

Adapt this dietary pattern to appropriate calorie requirements, personal and cultural food preferences, and nutrition therapy for other medical conditions

Reduce % of calories from saturated fat
Reduce % of calories from trans fat

17
Q

Metabolic Syndrome

A

MetS predicts development of both diabetes and CVD.

Insulin resistance and obesity characterise most individual subjects with the MetS

Initial therapy for the MetS should consist of diet modification and increased PA

Some of the conditions associated with MetS include obesity, high BP, dyslipidaemia and insulin resistance

18
Q

Glucose

A

Muscle contraction moves glucose into the cell via glut-4, independent of insulin

Glucose oxidation during exercise:

  • muscle contraction-mediated glucose uptake [non-insulin]
  • increased metabolic rate and fat oxidation

Insulin sensitive effects:
-postprandial

19
Q

Hypertension:

A

Acute endurance training session [1 session] can have a significant reduction in BP [~6mmHg] up to 24 hrs

Chronic endurance training significant reductions in BP however no real reductions after 10 weeks

Besides the metabolic and endocrine changes, there’s a mechanical adaptation :
- Left ventricular hypertrophy [LVH]
=hypertension causes LVH, endurance exercise training decreases LV mass [~12%]

20
Q

Hypertension & Endurance training:

A

Endurance training produce an almost immediate decrease [1-2weeks] of 5-7mmHg in bot SBP and DBP independent if weight loss

Reduces stroke and CAD risk by 30%

RT produces a lesser decrease of 3mmHg

Avoid intense exercise [aerobic & resistance] in patients with BP >180/85mmHg

21
Q

Hypertension : Mechanism for decrease in BP

A

Reduction on NE secretion
Increase in endothelia-derived nitric oxide due to sheer stress on blood vessel wall and vasodilation

Arterial stiffness is related to hypertension and CAD:

  • can be assessed by pulse wave analysis using pressure transducer on the brachial artery
  • endurance training [2-3h/wk] reduces arterial stiffness by 30%, without change in BP
22
Q

Drugs for treating MetS:

A

Antihypertensives:
- ACE inhibitors and ACE receptor inhibitors [Cato-ren, coversyl, avopro, tritace, atacand, micardis, karvea] = inhibits angiotensin converting enzyme action to reduce blood vol and reduces Vasoconstriction
~ Exercise consid= ACE do not affect exercise HR or exercise tolerance

  • Betablockers = BB receptors on cardiac muscle to reduce HR and hence BP
    =reduces resting and exercise HR in a dose-dependent basis
    ~exercise consid= cant use HR as guide to exercise intensity
  • Vasodilators = increases capacity of vascular system to lower BP
    ~ susceptible to fainting after exercise
  • Diuretics = action on kidney tubules to reduce reabsorption of sodium and increase potassium excretion
    =requires potassium replacement
    ~ causes cardiac arrhythmias

-Calcium Channel Blockers = reduce HR [negative chronotropic effect], reduces contraction to of cardiac muscle and vascular smooth muscle [negative ionotropic effect] and increases vasodilation
~cant use HR as guide to exercise intensity

Hypolipemic Agents:
- Statins = inhibitor of HMG CoA Reductase, thus reducing hepatic synthesis of chol
=reduces TC, LDL by 30-35% and increases HDL by 5-15%
~adverse reactions - 10-25% of patients on high dose statin meds

Hypoglycemic Agents:
- Metformin= med of choice for T2D and obesity
=increases insulin sensitivity

  • Sulphonureas = increases insulin secretion but may also cause weight gain

Insulin preparations:

  • short acting insulins = Actarapid [peak 3h lasts 8h], humalog [peak 1h lasts 4h]
  • longer acting insulin’s = protophana [peak 12h lasts 12-24h], lantus [last 24h]
23
Q

Describe Dyslipidaemia:

A

Abnormal blood lipids - can contribute to the development of atherosclerosis, a build up of fatty deposits in the blood vessels which may lead to the development of CV diseases

Dyslipidaemia is a risk factor for chronic disease such as CHD and stroke

24
Q

Drug therapy for Dyslipidaemia :

A

Statins:

  • reduce Total C 15-30%, lower LDL 20-40%
  • inhibits chol production in the liver and increase LDL receptors number in the hepatic and other tissues
  • LDL lowering with statins can decrease rate of heart attaCks and deaths form CHD ~30%
  • Effective in persons with or without CHD
  • can cause hepatotoxicity and myopathy [<1%]
  • contraindications: chronic liver disease, pregnancy

Nicotinic Acid [or niacin]:

  • lowering VLDL production and raises HDL
  • decrease HDL clearance = elevated HDL
  • can cause skin irritation and flushing, liver toxicity, hepatic failure
  • not recommended for individuals with hypotension

Fibric acid derivatives:

  • increase LPL activity - increase TRIG hydrolysis, and increased HDL 10-15%
  • also reduce fatty acid uptake by the liver = thereby slowing hepatic TRIG synthesis and VLDL production
  • side effects = GI distress, gallstones, myopathy

Probucol:

  • inhibits LDL oxidation = reduced risk of atherosclerosis
  • reported to decrease HDL, prolong QT interval on ECG

Bile acid sequestrate:

  • promotes chol elimination through the digestive tract by binding bile acids in the intestines
  • lower LDL and can be used alone or in combination with statin drugs
  • can cause gastric irritability, increase TRIG levels and constipation
  • interferes with absorption of warfarin, digoxin, and thyroxine
25
Q

Graded exercise testing:

A

Atherogenic blood profile is not a contraindication for exercise

But its a risk factor for CAD

Therefore must examine signs and symptoms of CAD

26
Q

Hyperlipidaemia : Exercise Testing

A

METHODS:

Aerobic:

  1. Cycle [ramp protocol 17 watts/min, staged protocol 25-50watts/ 3min stage]
  2. Treadmill [ 1-2METs/3min stage]

MEASURES:

  • 12 lead ECG, HR
  • BP, rate pressure product
  • RPE [6-20]
ENDPOINTS:
~ VO2peak/ work rate
~ serious dysrhythmias 
~ >2mm ST segment depression or elevation
~ ischemic threshold
~ T wave inversion with significant ST change 
~ SBP >250mmHG, DBP >115mmHg
~ Exaggerated or hypotensive response
~ volitional fatigue

METHOD
Endurance:
- 6min walk

MEASURE
-Distance

ENDPOINTS
- note time, distance, symptoms at rest stops

27
Q

Exercise Programming:

A

Minimum amount of exercise needed to improve blood lipids not known
A dose-response relationship between volume of PA and HDL has been identified

MODE:

  • RT doesn’t seem to alter fasting serum lipid and lipoprotein level, but data is limited
  • Aerobic training lower TRIG and elevates HDL

FREQUENCY:

  • HDL elevated 18-24h post exercise for 48-2h
  • <3 sessions per week

INTENSITY:
- Improvements in lipid profile observed with exercise at 50-60% HRmax

DURATION:

  • optimal duration not known
  • 45-60min is recommended